Sanjay Mistry

Vice President Venture Investments New Company Creation - Johnson & Johnson Innovation – JJDC Inc.
2021
Senior investment professional leading new company creation for Johnson & Johnson Innovation – JJDC, Inc., the strategic venture capital arm of the Johnson & Johnson Family of Companies. Primary responsibility is to fund compelling innovation where we see an opportunity to transform and enhance patient outcomes through the creation of innovative healthcare start-up companies.
Head JLABS @ San Diego, Johnson & Johnson Innovation
2019 - 2021
Nurtured the growth of San Diego’s entrepreneurial start-ups focusing on accelerating the pace of innovation that is critical for translating discoveries into products for patients
Senior Finance Director Business Operations for Janssen Pharmaceuticals R&D
2018 - 2019
Reported to Janssen Pharmaceuticals R&D CFO
Head of External Value Creation & Business Operations/Venture Leader
2013 - 2018
Led Janssen R&D efforts on launching NewCo’s via the out-licensing of R&D pre-clinical/clinical portfolio assets to biotech’s, pharma’s or into venture backed entities Led Janssen R&D Internal Venture Incubator operations focused on disruptive drug discovery assets/platforms that could generate new business models/innovation within or external to Janssen beyond core strategic focus areas EIR for 2 internal ventures

2022 - 2024

2008 - 2013

Vice President
2008 - 2013
Board Observer Roles: Raindance Technologies, Tarsa Therapeutics, Corridor Pharmaceuticals, Rapid Micro Biosystems, Durata Therapeutics (PIPE)

2003 - 2008

Assistant Director
2003 - 2008
Inventor of cell therapy for the treatment of age-related macular degeneration (Phase iIIb)

Morphogen Pharmaceuticals

2002 - 2003

Development Scientist
2002 - 2003
Established stem cell molecular biology group and discovered and developed muscle derived stem cell platform

2000 - 2001

Postdoctoral Fellow
2000 - 2001
Investigated the role of neural cell adhesion molecules in the initiation of stem cell differentiation and integration in targeted organogenesis (Laboratory of Dr. G. Edelman, Nobel laureate)

1998 - 2000

Postdoctoral Fellow
1998 - 2000
Department of Biochemistry: Investigated the role of arginase in arginine metabolism in wound healing and trauma (Laboratory of Dr. S. Morris)

Vice President Venture Investments New Company Creation - Johnson & Johnson Innovation – JJDC Inc.